Group One Trading, L.P. Immunic, Inc. Transaction History

Group One Trading, L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.14 - $1.53 $47 - $64	42 New	42 $0
Q3 2023 Nov 09, 2023	SELL	$1.35 - $2.87 $564 - $1,199	-418 Reduced 49.41%	428 $0
Q2 2023 Aug 09, 2023	SELL	$1.33 - $2.51 $13,402 - $25,293	-10,077 Reduced 92.25%	846 $2,000
Q1 2023 May 12, 2023	SELL	$1.35 - $2.87 $72,288 - $153,679	-53,547 Reduced 83.06%	10,923 $16,000
Q4 2022 Feb 09, 2023	BUY	$1.13 - $10.8 $48,270 - $461,343	42,717 Added 196.37%	64,470 $90,000
Q3 2022 Nov 09, 2022	BUY	$3.0 - $5.49 $64,038 - $117,189	21,346 Added 5244.72%	21,753 $69,000
Q2 2022 Aug 11, 2022	SELL	$3.13 - $12.25 $54,934 - $214,999	-17,551 Reduced 97.73%	407 $1,000
Q1 2022 May 12, 2022	BUY	$9.54 - $14.26 $102,612 - $153,380	10,756 Added 149.35%	17,958 $203,000
Q4 2021 Feb 11, 2022	BUY	$7.34 - $10.25 $42,454 - $59,286	5,784 Added 407.9%	7,202 $69,000
Q3 2021 Nov 12, 2021	BUY	$8.05 - $13.29 $11,414 - $18,845	1,418 New	1,418 $13,000
Q4 2020 Feb 10, 2021	SELL	$14.8 - $20.37 $8,051 - $11,081	-544 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$11.74 - $22.0 $5,940 - $11,132	506 Added 1331.58%	544 $10,000
Q3 2019 Nov 12, 2019	BUY	$10.0 - $17.01 $380 - $646	38 New	38 $0

56.2M

100

350K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $33M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.